VLA 0.00% $1.75 viralytics limited

Thanks for all the reports. As for "They are in no rush, and...

  1. 11,700 Posts.
    lightbulb Created with Sketch. 1689
    Thanks for all the reports.

    As for "They are in no rush, and that may well be in our long term interest.". Big pharma may well be in a rush, as it is probably in their interest to get access to CAVATAK and stop their competitors from getting it.

    There are some very exciting months coming up imho.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.